0001493152-24-033277.txt : 20240820 0001493152-24-033277.hdr.sgml : 20240820 20240820163517 ACCESSION NUMBER: 0001493152-24-033277 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240815 FILED AS OF DATE: 20240820 DATE AS OF CHANGE: 20240820 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bailey Gregory CENTRAL INDEX KEY: 0001329505 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38519 FILM NUMBER: 241225679 MAIL ADDRESS: STREET 1: 4 A CHESHAM STREET CITY: LONDON STATE: X0 ZIP: SW1X8DT ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Serina Therapeutics, Inc. CENTRAL INDEX KEY: 0001708599 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 821436829 STATE OF INCORPORATION: AL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 601 GENOME WAY STREET 2: SUITE 2001 CITY: HUNTSVILLE STATE: AL ZIP: 35806 BUSINESS PHONE: (256) 327-9630 MAIL ADDRESS: STREET 1: 601 GENOME WAY STREET 2: SUITE 2001 CITY: HUNTSVILLE STATE: AL ZIP: 35806 FORMER COMPANY: FORMER CONFORMED NAME: AgeX Therapeutics, Inc. DATE OF NAME CHANGE: 20170606 4 1 ownership.xml X0508 4 2024-08-15 0 0001708599 Serina Therapeutics, Inc. SER 0001329505 Bailey Gregory 601 GENOME WAY, SUITE 2001 HUNTSVILLE AL 35806 1 0 0 0 0 Common Stock 2024-08-15 4 P 0 6400 6.6526 A 33006 D Common Stock 2024-08-16 4 P 0 6400 7.3093 A 39406 D Common Stock 2024-08-19 4 P 0 6400 7.9313 A 45806 D The price reflects the weighted average purchase price of multiple transactions ranging from a low of $6.55 per share to a high of $7.94 per share. Upon the written request of the SEC, the issuer or a security holder of the issuer, the reporting person agrees to provide the number of shares sold at each sale price. The price reflects the weighted average purchase price of multiple transactions ranging from a low of $7.12 per share to a high of $8.02 per share. Upon the written request of the SEC, the issuer or a security holder of the issuer, the reporting person agrees to provide the number of shares sold at each sale price. The price reflects the weighted average purchase price of multiple transactions ranging from a low of $7.24 per share to a high of $8.57 per share. Upon the written request of the SEC, the issuer or a security holder of the issuer, the reporting person agrees to provide the number of shares sold at each sale price. /s/ Gregory Bailey 2024-08-20